CoChat

α-Ketoglutarate attenuates Wnt signaling and drives differentiation in colorectal cancer

Open access

The DOI matches its Crossref record; 64 of the 65 references it cites were found in a registry or an index, and 1 are not checked yet.

Abstract

Genetic-driven deregulation of the Wnt pathway is crucial but not sufficient for colorectal cancer (CRC) tumourigenesis. Here, we show that environmental glutamine restriction further augments Wnt signaling in APC mutant intestinal organoids to promote stemness and leads to adenocarcinoma formation in vivo via decreasing intracellular alpha-ketoglutarate (aKG) levels. aKG supplementation is sufficient to rescue low-glutamine induced stemness and Wnt hyperactivation. Mechanistically, we found that aKG promotes hypomethylation of DNA and histone H3K4me3, leading to an upregulation of differentiation-associated genes and downregulation of Wnt target genes, respectively. Using CRC patient-derived organoids and several in vivo CRC tumour models, we show that aKG supplementation suppresses Wnt signaling and promotes cellular differentiation, thereby significantly restricting tumour growth and extending survival. Together, our results reveal how metabolic microenvironment impacts Wnt signaling and identify aKG as a potent antineoplastic metabolite for potential differentiation therapy for CRC patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s43018-020-0035-5

Cites

64 of 65 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 65 references

Cited by

See all 177

Metadata

Authors
Tran, T. Q., Hanse, E. A., Habowski, A. N., Li, H., Ishak Gabra, M. B., Yang, Y., Lowman, X. H., Ooi, A. M., Liao, S. Y., Edwards, R. A., Waterman, M. L., & Kong, M.
Affiliations
  • University of California, Irvine (US)
  • City Of Hope National Medical Center (US)
Corresponding author
Kong, Mei
Venue
Nature Cancer
Published
2020-03-20
Volume
1
Issue
3
Pages
345-358
ISSN
2662-1347 (ISSN-L)
OpenAlex
W3012399094
Cited by
161
References
65
Citations by year
2026: 17 · 2025: 34 · 2024: 26 · 2023: 30 · 2022: 29 · 2021: 14 · 2020: 11
FWCI
6.81
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Cancer (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • National Science Foundation (DGE‐1321846grantnumber>)
  • American Cancer Society (PFDDC-132846, RSG-16-085-01-TBE)
  • U.S. Department of Health & Human Services | NIH | National Cancer Institute (T32CA009054, R01CA17765, U54CA217378, R01CA183989)
  • U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM132142)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Keywords
alpha-ketoglutarate, Wnt signaling, colorectal cancer, APC mutation, intestinal organoids, cancer stemness, cell differentiation, DNA hypomethylation, histone H3K4me3, differentiation therapy, tumor growth inhibition
MeSH terms
Glutamine, Humans, Ketoglutaric Acids, Organoids, Colorectal Neoplasms, Tumor Microenvironment, Wnt Signaling Pathway

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: α-Ketoglutarate attenuates Wnt signaling and drives differentiation in colorectal cancer. https://app.cochat.ai/papers/10.1038/s43018-020-0035-5
The paper
Tran, T. Q., Hanse, E. A., Habowski, A. N., Li, H., Ishak Gabra, M. B., Yang, Y., Lowman, X. H., Ooi, A. M., Liao, S. Y., Edwards, R. A., Waterman, M. L., & Kong, M. (2020). α-Ketoglutarate attenuates Wnt signaling and drives differentiation in colorectal cancer. Nature Cancer. https://doi.org/10.1038/s43018-020-0035-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.